CYSTEINE HYDROCHLORIDE ANHYDROUS
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 121.0 | -0.7 | 3 | 3 | 63.0 | 2 | 0.67 |
- CAS
- 52891
- UNII
- A9U1687S1S
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 106 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02348775 | 2014-11-01 | Glutathione and Function in HIV Patients | Phase 1 | Recruiting |
| NCT02348762 | 2014-11-01 | Energetics and Function in Older Humans | Phase 1 | Recruiting |
| NCT02252341 | 2014-09-01 | Efficacy of N-Acetyl-Cysteine in Bipolar Disorder and Tobacco Use Disorder | Phase 4 | Enrolling By Invitation |
| NCT02206152 | 2014-07-01 | A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes | Phase 1/Phase 2 | Not Yet Recruiting |
| NCT02117700 | 2014-05-01 | Fatty Liver Disease in Obese Children | Phase 2 | Not Yet Recruiting |
| NCT02050139 | 2014-02-01 | L-Cysteine in Peritoneal Dialysis | Phase 2 | Recruiting |
| NCT02124941 | 2014-02-01 | Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 13C-MRS | Phase 1 | Recruiting |
| NCT01840345 | 2014-01-01 | The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain | Phase 2 | Recruiting |
| NCT01820195 | 2013-03-01 | N-Acetyl Cystein and Contrast Nephropathy | Phase 3 | Recruiting |
| NCT01841411 | 2013-03-01 | Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis | Phase 4 | Recruiting |
| NCT01878669 | 2013-01-01 | Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention | Phase 3 | Recruiting |
| NCT01797575 | 2013-01-01 | N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder | Phase 2 | Recruiting |
| NCT01063348 | 2012-09-01 | N-Acetyl Cysteine in Pathologic Skin Picking | Phase 2 | Recruiting |
| NCT02239107 | 2012-01-01 | N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary Syndrome | Phase 4 | Completed |
| NCT01339858 | 2011-05-01 | The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage Schizophrenia | Phase 4 | Recruiting |
| NCT01403506 | 2011-04-01 | Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL) | Phase 3 | Recruiting |
| NCT01614431 | 2011-03-01 | N Acetyl Cysteine for Cystinosis Patients | Phase 4 | Completed |
| NCT01322009 | 2011-03-01 | Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury | Phase 1/Phase 2 | Recruiting |
| NCT01251315 | 2010-12-01 | The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels | Phase 1 | Completed |
| NCT01241513 | 2010-11-01 | Induced Changes in Ventilatory Responsiveness and Altitude Exposure | Phase 4 | Completed |
| NCT01355198 | 2010-08-01 | Role of HIV on Glutathione Synthesis and Oxidative Stress | Phase 1 | Completed |
| NCT01099332 | 2009-11-01 | Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease | Phase 1/Phase 2 | Active, Not Recruiting |
| NCT00967005 | 2009-09-01 | N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers | Phase 2 | Active, Not Recruiting |
| NCT00975689 | 2009-08-01 | Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine | Phase 1/Phase 2 | Completed |
| NCT00866866 | 2009-03-01 | The Use of Oral N-Acetyl Cysteine for the Treatment of Chronic Sinonasal Symptoms | Phase 4 | Recruiting |
| NCT00829205 | 2009-01-01 | Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | Phase 1/Phase 2 | Withdrawn |
| NCT00676195 | 2008-06-01 | An Open-Label Study of N-Acetyl Cysteine in Children With Autism | Phase 2 | Completed |
| NCT00627705 | 2008-02-01 | A Study of N-Acetyl Cysteine in Children With Autism | Phase 2 | Completed |
| NCT00489372 | 2007-07-01 | Se-Methyl-Seleno-L- Cysteine (MSC) in Treating Healthy Patients | Phase 1 | Completed |
| NCT00254176 | 2006-09-01 | Cysteine Supplementation in Critically Ill Neonates | Phase 2/Phase 3 | Active, Not Recruiting |
| NCT00354770 | 2006-07-01 | N-Acetyl Cysteine in Trichotillomania | Phase 2 | Completed |
| NCT00332605 | 2006-06-01 | N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence | Phase 2 | Completed |
| NCT00273702 | 2006-01-01 | An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling | Phase 1 | Completed |
| NCT00863785 | 2004-04-01 | Treatment of Severe Alcoholic Hepatitis With Corticoids Plus N Acetyl Cysteine Versus Corticoids Alone | Phase 3 | Completed |
| NCT01506765 | 2003-08-01 | Schizophrenia, Related Troubles and Glutathione: Clinical Trial. Effects of Oral Administration of N-Acetylcysteine (NAC) on the Brain Glutathione Level and on the Symptoms of Schizophrenia | Phase 1 | Completed |
| NCT00004940 | 1996-05-01 | Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria | Phase 3 | Completed |